⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1578643 | 1.00 | — | — | |
| SCHEMBL263323 | 1.00 | — | — | |
| SCHEMBL4581876 | 0.74 | — | — | |
| SCHEMBL2164098 | 0.74 | — | — | |
| SCHEMBL2164096 | 0.74 | — | — | |
| SCHEMBL2889398 | 0.72 | — | — | |
| SCHEMBL2771545 | 0.72 | — | — | |
| SCHEMBL713956 | 0.72 | — | — | |
| SCHEMBL3693617 | 0.72 | — | — | |
| SCHEMBL6801405 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240200138-A1 | Target-Enriched Multiplexed Parallel Analysis For Assessment Of Risk For Genetic Conditions | MEDICOVER PUBLIC CO LTD (CY) | 2024-06-20 | — | — | US | claimed |
| CN-113631562-B | Novel compounds and uses thereof | 长濑产业株式会社 | 2024-04-19 | — | — | CN | claimed |
| US-11879157-B2 | Target-enriched multiplexed parallel analysis for assessment of risk for genetic conditions | NIPD GENETICS PUBLIC COMPANY LIMITED (CY) | 2024-01-23 | — | — | US | claimed |
| US-20220177507-A1 | NOVEL COMPOUND AND USE OF SAME | NAGASE & CO., LTD. (JP) | 2022-06-09 | — | — | US | claimed |
| EP-3649259-B1 | TARGET-ENRICHED MULTIPLEXED PARALLEL ANALYSIS FOR ASSESSMENT OF RISK FOR GENETIC CONDITIONS | NIPD GENETICS PUBLIC COMPANY LTD (CY) | 2022-05-25 | — | — | EP | claimed |
| EP-3950697-A1 | NOVEL COMPOUND AND USE OF SAME | Nagase & Co., Ltd. (JP) | 2022-02-09 | — | — | EP | claimed |
| CN-113631562-A | Novel compounds and their use | 长濑产业株式会社 | 2021-11-09 | — | — | CN | claimed |
| US-20210277419-A1 | Genome Editing without Nucleases | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2021-09-09 | — | — | US | claimed |
| US-20210147937-A1 | TARGET-ENRICHED MULTIPLEXED PARALLEL ANALYSIS FOR ASSESSMENT OF RISK FOR GENETIC CONDITIONS | MEDICOVER PUBLIC CO LTD (CY) | 2021-05-20 | — | — | US | claimed |
| US-20210017539-A1 | Genome Editing without Nucleases | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2021-01-21 | — | — | US | claimed |
| US-5189027-A | Hypotensive agent, vasoconstriction | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1993-02-23 | — | — | US | claimed |
| WO-1992021682-A1 | PROCESSES FOR THE PREPARATION OF CEPHALOSPORINS AND OF PHARMACEUTICAL COMPOSITION CONTAINING THEM | BEECHAM GROUP P.L.C. (GB) | 1992-12-10 | — | — | WO | claimed |
| EP-0504216-A1 | CEPHALOSPORINS, PROCESSES FOR THEIR PREPARATION, INTERMEDIATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Beecham Group p.l.c. (GB) | 1992-09-23 | — | — | EP | claimed |
| US-5068340-A | Antagonist of platelet activating factor for treatment of asthma, inflammation or shock | SANKYO COMPANY, LIMITED (JP) | 1991-11-26 | — | — | US | claimed |
| EP-0124366-B1 | METHOD OF MEASURING BIOLOGICAL LIGANDS | FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. (JP) | 1991-10-30 | — | — | EP | claimed |
| WO-1991009038-A1 | CEPHALOSPORINS, PROCESSES FOR THEIR PREPARATION, INTERMEDIATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BEECHAM GROUP PLC (GB) | 1991-06-27 | — | — | WO | claimed |
| EP-0289219-A2 | Method of measuring biotin | FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. (JP) | 1988-11-02 | — | — | EP | claimed |
| US-4649105-A | IMMUNOLOGY, ANTIBODY AND ENZYMES, INHIBITORS | FUJIREBIO KABUSHIKI KAISHA (JP) | 1987-03-10 | — | — | US | claimed |
| EP-0132292-A2 | Method of measuring biological ligands | FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. (JP) | 1985-01-30 | — | — | EP | claimed |
| EP-0124366-A2 | Method of measuring biological ligands | FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. (JP) | 1984-11-07 | — | — | EP | claimed |